High-risk prostate cancer patients benefit from perioperative apalutamide therapy
High-risk localized and locally advanced prostate cancer patients treated with apalutamide – a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI)…
Breaking health news, medical updates, policy changes, and public health developments from around the world. We deliver timely, accurate health journalism to keep you informed and aware.
High-risk localized and locally advanced prostate cancer patients treated with apalutamide – a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI)…
At the ASCO annual meeting, Dana-Farber’s Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing…
Scientists from Tokyo Metropolitan University have revealed key parts of the biochemical pathways connecting stress to sexual dysfunction. By studying…
A multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that implanting…
Worldwide, at least 40 million children aged 13–15 use tobacco products, and young people’s use of e-cigarettes and nicotine pouches…
Salaera, a leading innovator and manufacturer of respiratory care, gas delivery and gas analysis technologies, has been named “Healthcare Company…
Chronic stress, depression, cardiovascular disease, fragmented sleep, and aging are all associated with a higher risk of dementia, but scientists…
Cleveland Browns cornerback and American Heart Association Nation of Lifesavers™ NFL Player Ambassador Denzel Ward is taking his impact beyond the field…
In a new study published in JAMA, the diagnostic yield of transbronchial lung biopsy was significantly higher when using a…
One way to lower smoking rates among teens may be to address their exposure to violence, as an analysis from…